ustekinumab, secukinumab, ixekizumab.** High-quality evidence Studies that provide high confidence in the effect estimate, and new data from future studies are thought unlikely to change the effect. Moderate-quality evidence Studies that provide confidence that the true effect is likely to be close to the estimate but could be substantially different. Low-quality evidence Studies that provide limited confidence about the effect, and the true effect may be substantially different from the